Welcome to the NovioSense Press Room

We hope to be able to provide an oversight of NovioSense, and to provide you with substantial information for your message. If the information you require is not included, please contact us.

Press Releases

October 2018 – Postive phase 2 clinical trial results

October 2016 – NovioSense announces successful clinical trial and fourth investment round

July 2015 – Gentag, Mayo Clinic, NovioSense and Fraunhofer Join forces

November 2014 – Issue of First NovioSense Patent 

NovioSense Introduction

NovioSense is finger prick glucose reinvented. The NovioSense platform consists of a flexible spring like sensor unit connected to two microchips developed by NovioSense and Fraunhofer.  The NovioSense Glucose sensor is a small flexible device that sits in the lower eye lid and continually measures glucose levels in tear fluid. The device is powered and data is read out by means of a wireless protocol compatible with that used in NFC enabled mobile phones. The device can measure both continually and on demand.

Download Product Photo (right click and save as)

Download Promo Photo (right click and save as)

For more information please download our non-confidential teaser

Download Non-Confidential Teaser (right click and save as)